Monthly Archives: September 2022

Patents as a secondary exclusivity driver for new repurposed medicinal products

Hutchinson-Gilford Progeria syndrome is a rare genetic disease involving accelerated aging

Hutchinson-Gilford Progeria syndrome is a rare genetic disease that causes accelerated ageing Drug repurposing is often regarded as a cinderella child of new medicine discovery because ‘old drugs have expired patent exclusivities and the commercial opportunity is absent’. This is an erroneous view, because, in the first place, there are multiple ways to patent an […]